- Presentation to highlight milestones including phase III development of
'GI-friendly' NSAIDs for mild to moderate pain -
PALO ALTO, Calif., Oct. 5 /PRNewswire/ --
What: Horizon Therapeutics, Inc. is pleased to announce that
George Tidmarsh, M.D., Ph.D., chief executive officer, will
showcase Horizon's corporate and clinical milestones,
including its recent completion of Series C financing, and
provide an update on the development of the Company's
product pipeline during an Open House Podium Presentation
at BioPartnering Europe (BPE). Immediately following the
presentation Dr. Tidmarsh will be available to field
questions and provide more detailed information on Horizon
Therapeutics.
BPE was first held in London in 1993 as a partnership
between the U.S. Commercial Service and Technology Vision
Group LLC to bring about closer ties between American and
European biotechnology companies. From the beginning, BPE
has attracted the support of leading pharmaceutical,
biotechnology, financial and service companies that have
all contributed to making BPE one of the leading
independent partnering events in the world. BPE has a high
rate of sponsor retention, which indicates its prominent
position on the annual conference calendar for many
industry leaders.
When: Monday, October 8, 2007
9:30 a.m. - 12:45 p.m. Open House Podium Presentation
(10:45-10:55 a.m. Horizon presentation)
Where: London, England
QEII Conference Centre
'/>"/>| SOURCE Horizon Therapeutics, Inc. Copyright©2007 PR Newswire. All rights reserved |